(115 days)
P050014, P990066
Not Found
No
The summary describes a digital mammography system with advanced hardware (photon counting detector, multi-slit scanning) and exposure control modes (manual, automatic, SmartAEC). While it mentions image processing, there is no mention of AI, ML, deep learning, or any related terms or concepts in the device description, intended use, or performance studies. The focus is on the physical technology and exposure control mechanisms.
No.
The device is indicated for generating diagnostic images, not delivering therapy.
Yes
The Intended Use / Indications for Use section states that the device is "indicated for generating mammographic images that can be used for screening and diagnosis of breast cancer."
No
The device description clearly outlines hardware components such as an image acquisition system, gantry, digital detector, x-ray tube, high voltage generator, compression paddle(s), and multi-slit collimator. While it includes software for image processing and user interface, it is fundamentally a hardware-based system.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- Device Function: The Sectra MicroDose Mammography L30 is an imaging system that uses X-rays to create images of the breast. It does not analyze biological samples.
- Intended Use: The intended use is for generating mammographic images for screening and diagnosis of breast cancer, which is a direct imaging procedure, not an in vitro test.
The device description and intended use clearly indicate it's an imaging device, not a device used for testing samples outside the body.
N/A
Intended Use / Indications for Use
The Sectra MicroDose Mammography L30 is indicated for generating mammographic images that can be used for screening and diagnosis of breast cancer. The Sectra MicroDose Mammography L30 is intended to be used in the same clinical applications as traditional film/screen systems.
Product codes (comma separated list FDA assigned to the subject device)
MUE
Device Description
The Sectra MicroDose Mammography L30 is a type of full-field digital mammography system comprised of an image acquisition system, a gantry and an acquisition workstation computer equipped with a keyboard, a keypad, a mouse, and a monitor. The image acquisition system includes a digital detector of photon counting technology, x-ray tube (with tungsten target and aluminum filtration), high voltage generator, compression paddle(s), and multi-slit collimator. The acquisition workstation is the user interface for preparing and initiating image acquisition, image processing, and image transfer to the desired destination (e.g. PACS) for diagnosis and archiving.
The Sectra MicroDose Mammography 130 detector is based on photon counting technology and consists of a large number of crystalline silicon strip detectors. The technology enables high detection efficiency of photons and efficient rejection of electronic noise. The Sectra MicroDose Mammography L30 uses a multi-slit scanning technique that prevents image degradation caused by scattered radiation by removing photons scattered in the breast and not directed towards the detector. These factors combine into a dose efficient system.
The Sectra MicroDose Mammography L30 provides three exposure modes; manual, automatic (parameters predefined based on compressed breast thickness), and SmartAEC. SmartAEC continuously adjusts the exposure based on measured transmission from the leading detector edge.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray
Anatomical Site
Breast
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance data from non-clinical testing of the Sectra MicroDose Mammography L30 covering Sensitometric response, Spatial resolution, Noise analysis, Signal-to-noise-ratio transfer – DQE, Dynamic range, Automatic exposure control performance, Phantom testing, Patient radiation dose, and Image erasure, fading and repeated exposure was compared with data from the PMA Summary of Safety and effectiveness of the predicate devices. This comparison showed that the Sectra MicroDose Mammography L30 device performed as well as or better than the predicate devices in all relevant areas. The testing was performed in accordance with generally accepted test methods, e.g. using IEC standards, published factors for dose calculations etc.
An image attribute evaluation was conducted in accordance with the Guidance for Industry and FDA Staff, Class II Special Controls Guidance Document: Full-Field Digital Mammography System [issued: November 5, 2010] which concluded that the images were of sufficiently acceptable quality for clinical mammographic usage.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
P050014, P990066
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1715 Full-field digital mammography system.
(a)
Identification. A full-field digital mammography system is a device intended to produce planar digital x-ray images of the entire breast. This generic type of device may include digital mammography acquisition software, full-field digital image receptor, acquisition workstation, automatic exposure control, image processing and reconstruction programs, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). The special control for the device is FDA's guidance document entitled “Class II Special Controls Guidance Document: Full-Field Digital Mammography System.”See § 892.1(e) for the availability of this guidance document.
0
Image /page/0/Picture/0 description: The image shows the word "SECTRA" in large, bold, black letters. The letters are slightly distressed, giving them a textured appearance. The font is sans-serif and the letters are evenly spaced.
Image /page/0/Picture/1 description: The image contains a sequence of characters that appear to be handwritten. The sequence starts with the letter 'K', followed by the number '1' repeated twice, then two zeros '00', the letter 'd', and ends with the number '5'. The characters are written in a dark ink, and the handwriting style is somewhat cursive, particularly in the formation of the 'd' and '5'.
510(k) Summary (21 CFR 807.92)
APR 2 8 2011
A. SUBMITTER INFORMATION
| Submitter's name | Sectra Imtec AB |
|---|---|
| Address | Teknikringen 20 |
| SE-583, 30 Linköping | |
| Sweden | |
| Establishment registration | |
| number | 9615992 |
| Contact person | Alexander Asklöv |
| Telephone | +46-13-23 52 00 |
| FAX | +46-13-21 21 85 |
| Title | Chief Quality Officer of product division |
| mammography at Sectra Imtec AB | |
| Date of the summary preparation | 2010-12-30 |
B. DEVICE IDENTIFICATION
Device trade name Device common name Classification name Classification product code Device class Regulation code
Sectra MicroDose Mammography L30 Full-Field Digital Mammography X-ray System Full-Field Digital Mammography X-ray System MUE ll
21 CFR 892.1710 ﮐ
:
C. DEVICE DESCRIPTION
The Sectra MicroDose Mammography L30 is a type of full-field digital mammography system comprised of an image acquisition system, a gantry and an acquisition workstation computer equipped with a keyboard, a keypad, a mouse, and a monitor. The image acquisition system includes a digital detector of photon counting technology, x-ray tube (with tungsten target and aluminum filtration), high voltage generator, compression paddle(s), and multi-slit collimator. The acquisition workstation is the user interface for preparing and initiating image acquisition, image processing, and image transfer to the desired destination (e.g. PACS) for diagnosis and archiving.
The Sectra MicroDose Mammography 130 detector is based on photon counting technology and consists of a large number of crystalline silicon strip detectors. The technology enables high detection efficiency of photons and efficient rejection of electronic noise. The Sectra MicroDose Mammography L30 uses a multi-slit scanning technique that prevents image degradation caused by scattered radiation by removing photons scattered in the breast and not directed towards the detector. These factors combine into a dose efficient system.
The Sectra MicroDose Mammography L30 provides three exposure modes; manual, automatic (parameters predefined based on compressed breast thickness), and SmartAEC. SmartAEC
1
Image /page/1/Picture/0 description: The image shows the word "SECTRA" in large, bold, black letters. The letters have a slightly distressed or textured appearance, as if they were stamped or printed with a worn-out ink. The word is presented in a straightforward, horizontal arrangement, with each letter clearly legible against the white background. The overall impression is one of a strong, industrial-style typeface.
continuously adjusts the exposure based on measured transmission from the leading detector edge.
D. INDICATIONS FOR USE
The Sectra MicroDose Mammography L30 is indicated for generating mammographic images that can be used for screening and diagnosis of breast cancer. The Sectra MicroDose Mammography L30 is intended to be used in the same clinical applications as traditional film/screen systems.
E. PREDICATE DEVICES
| Predicate device #1 | Predicate device #2 | |
|---|---|---|
| Trade Name | FUJI'S COMPUTED RADIOGRAPHY | |
| MAMMOGRAPHY SUITE (FCRMS) | SENOGRAPHE 2000D | |
| Classification | ||
| Name | Full Field Digital, System, X-ray, | |
| Mammographic | Full Field Digital, System, X-ray, | |
| Mammographic | ||
| Generic Name | Fuji CR-IR348CL Image Console With | |
| FCRMS Software | Digital Mammographic X-ray System | |
| PMA Applicant | FUJIFILM MEDICAL SYSTEM U.S.A., | |
| INC. | GE HEALTHCARE | |
| PMA Number | P050014 | P990066 |
| Product Code | MUE | MUE |
| Advisory | ||
| Committee | Radiology | Radiology |
ப TECHNICAL CHARACTERISTICS
The Sectra MicroDose Mammography L30 System does not employ exactly the same type of detector as the predicate devices and the readout methods are different, however the fundamental process of digital full field mammographic image creation remains the same for all three devices; x-ray photons are captured in the detector and ultimately converted to an electrical signal, forming a digital image.
Performance data from non-clinical testing of the Sectra MicroDose Mammography L30 covering Sensitometric response, Spatial resolution, Noise analysis, Signal-to-noise-ratio transfer – DQE, Dynamic range, Automatic exposure control performance, Phantom testing, Patient radiation dose, and Image erasure, fading and repeated exposure was compared with data from the PMA Summary of Safety and effectiveness of the predicate devices. This comparison showed that the Sectra MicroDose Mammography L30 device performed as well as or better than the predicate devices in all relevant areas. The testing was performed in accordance with generally accepted test methods, e.g. using IEC standards, published factors for dose calculations etc.
An image attribute evaluation was conducted in accordance with the Guidance for Industry and FDA Staff, Class II Special Controls Guidance Document: Full-Field Digital Mammography System [issued: November 5, 2010] which concluded that the images were of sufficiently acceptable quality for clinical mammographic usage.
2
Image /page/2/Picture/0 description: The image shows the word "SECTRA" in a bold, sans-serif font. The letters are filled with a textured pattern, giving them a distressed or grunge appearance. The overall impression is of a strong, industrial, or perhaps even vintage design.
G. conclusion
The Sectra MicroDose Mammography L30 described in this substantially equivalent to the predicate devices in respects of indication for use and image quality. The proposed and predicate devices utilize similar technology and materials, comparable safety and effectiveness features, and are similar in design and construction. The information submitted in this application shows that none of the technical differences between the systems raises new questions of safety and effectiveness. All collected performance data demonstrate that the devices are substantially equivalent. Our conclusion is that Sectra MicroDose Mammography L30 is as safe and effective as the legally marketed predicate devices.
3
Image /page/3/Picture/0 description: The image shows the logo for the Department of Health & Human Services USA. The logo features a stylized eagle with three tail feathers. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circle around the eagle.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Mr. Alexander Asklöv Chief Quality Officer Sectra Imtec AB - Product Division Mammography Teknikrigen 20 Linköping SE-58330 SWEDEN
APR 2 8 2011
Re: K110025
Trade/Device Name: Sectra MicroDose Mammography L30 Regulation Number: 21 CFR 892.1715 Regulation Name: Mammographic x-ray system Regulatory Class: II Product Code: MUE Dated: April 15, 2011 Received: April 19, 2011
Dear Mr. Asklöv:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
4
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket wification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 11 you don't openice as not in Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office
of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours,
Mary Patel
Mary S. Pastel, Sc.D. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Device Name:
Sectra MicroDose Mammography L30
Indications for Use:
The Sectra MicroDose Mammography L30 is indicated for The Sectra MicroDoso Mic images that can be used for screening and diagnosis of breast cancer.
and Glaghosis of Steast Mammography L30 is intended to be used in the same clinical applications as traditional film/screen systems.
Prescription Use __ X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use _ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mury S. Potts
(Division Sign-Off)
..............................................................................................................................................................................
(Division Sign Off)
Division of Radiological Devices
Office of In Vitro Diagnostic Device Evaluation and Safety
610K. K1100.25
Page 1 of 1